Literature DB >> 16998604

Fmr1 KO mice as a possible model of autistic features.

Maude Bernardet1, Wim E Crusio.   

Abstract

Autism is a pervasive developmental disorder appearing before the age of 3, where communication and social interactions are impaired. It also entails stereotypic behavior or restricted interests. Although this disorder was first described in 1943, little is still known about its etiology and that of related developmental disorders. Work with human patients has provided many data on neuropathological and cognitive symptoms, but our understanding of the functional defects at the cellular level and how they come about remains sketchy. To improve this situation, autism research is in need of valid animal models. However, despite a strong hereditary component, attempts to identify genes have generally failed, suggesting that many different genes are involved. As a high proportion of patients suffering from the Fragile X Syndrome show many autistic symptoms, a mouse model of this disorder could potentially also serve as a model for autism. The Fmr1 KO mouse is a valid model of the Fragile X Syndrome and many data on behavioral and sensory-motor characteristics of this model have been gathered. We present here an assessment of autistic features in this candidate model. We conclude that Fmr1 KO mice display several autistic-like features, but more work is needed to validate this model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16998604      PMCID: PMC5917219          DOI: 10.1100/tsw.2006.220

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  64 in total

Review 1.  Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway.

Authors:  E Carla Parker-Athill; Jun Tan
Journal:  Neurosignals       Date:  2010-10-02

Review 2.  Modeling autistic features in animals.

Authors:  Paul H Patterson
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

3.  Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential.

Authors:  Wenzhong William Min; Christopher J Yuskaitis; Qijiang Yan; Christopher Sikorski; Shengqiang Chen; Richard S Jope; Robert P Bauchwitz
Journal:  Neuropharmacology       Date:  2008-10-14       Impact factor: 5.250

4.  The fragile X mental retardation protein: a valuable partner in the battle against epileptogenesis.

Authors:  Lisa R Merlin
Journal:  Epilepsy Curr       Date:  2009 Jul-Aug       Impact factor: 7.500

5.  Developmental and behavioral alterations in zebrafish embryonically exposed to valproic acid (VPA): An aquatic model for autism.

Authors:  Jiangfei Chen; Lei Lei; Linjie Tian; Fei Hou; Courtney Roper; Xiaoqing Ge; Yuxin Zhao; Yuanhong Chen; Qiaoxiang Dong; Robert L Tanguay; Changjiang Huang
Journal:  Neurotoxicol Teratol       Date:  2018-01-05       Impact factor: 3.763

6.  Enhanced Social Dominance and Altered Neuronal Excitability in the Prefrontal Cortex of Male KCC2b Mutant Mice.

Authors:  Allison M J Anacker; Jacqueline T Moran; Sara Santarelli; C Gunnar Forsberg; Tiffany D Rogers; Gregg D Stanwood; Benjamin J Hall; Eric Delpire; Jeremy Veenstra-VanderWeele; Michael D Saxe
Journal:  Autism Res       Date:  2019-04-12       Impact factor: 5.216

Review 7.  Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome.

Authors:  Gül Dölen; Mark F Bear
Journal:  J Physiol       Date:  2008-01-17       Impact factor: 5.182

Review 8.  Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.

Authors:  S M Francis; A Sagar; T Levin-Decanini; W Liu; C S Carter; S Jacob
Journal:  Brain Res       Date:  2014-01-22       Impact factor: 3.252

9.  GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism.

Authors:  Marjelo A Mines; Christopher J Yuskaitis; Margaret K King; Eleonore Beurel; Richard S Jope
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

10.  A mouse model of the human Fragile X syndrome I304N mutation.

Authors:  Julie B Zang; Elena D Nosyreva; Corinne M Spencer; Lenora J Volk; Kiran Musunuru; Ru Zhong; Elizabeth F Stone; Lisa A Yuva-Paylor; Kimberly M Huber; Richard Paylor; Jennifer C Darnell; Robert B Darnell
Journal:  PLoS Genet       Date:  2009-12-11       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.